Khayal Tamer I 4
4 · TransMedics Group, Inc. · Filed Nov 13, 2024
Insider Transaction Report
Form 4
Khayal Tamer I
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-11-11$38.46/sh+1,458$56,075→ 22,301 total - Sale
Common Stock
2024-11-11$90.04/sh−1,458$131,278→ 20,843 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-11−1,458→ 5,834 totalExercise: $38.46Exp: 2031-02-24→ Common Stock (1,458 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.